Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation.
Psaila B. and Mead AJ., (2019), Blood, 133, 1427 - 1435
Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion
ROBERTS IRENE. et al, (2019), Scientific Reports
Immunotherapy-related hepatitis: Real-world experience from a tertiary centre
Cheung V. et al, (2019), Frontline Gastroenterology
Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing.
Rodriguez-Meira A. et al, (2019), Mol Cell, 73, 1292 - 1305.e8
UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN.
Harrison C. et al, (2019), British journal of haematology
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
Woodcock VK. et al, (2019), JOURNAL OF CLINICAL ONCOLOGY, 37
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK
Harrison C. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 66 - 67
A Retrospective Real World Evidence Study To Review The Current Treatment Pathways for Myelofibrosis From Across The United Kingdom (The REALISM UK Study)
Mead A. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 8 - 9
Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138
The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
Butt NM. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 54 - 55
Whole genome sequencing for the investigation of rare anaemias: Challenges and real-world outcomes
Brierley C. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 115 - 116
Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly Diffuse large B cell lymphoma (DLBCL) patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age.
Eyre TA. et al, (2019), Journal of internal medicine
BRN2 suppresses apoptosis, reprograms DNA damage repair and is associated with a high somatic mutation burden in melanoma
GODING C. et al, (2019), Genes and Development
The Use of Digital Pathology and Image Analysis in Clinical Trials
Pell R. et al, (2019), The Journal of Pathology: Clinical Research
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical Trial.
Juric D. et al, (2019), JAMA oncology, 5, e184475 - e184475
Age-Related Changes in Tumoral Angiogenesis Drive Melanoma Metastasis and Response to Targeted Therapy
Ecker B. et al, (2019), ANNALS OF SURGICAL ONCOLOGY, 26, S38 - S39
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.
Eyre TA. et al, (2019), Haematologica, 104, e68 - e71
Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies.
Brierley CK. et al, (2019), Br J Haematol, 184, 547 - 557
Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study.
Gupta V. et al, (2019), Biol Blood Marrow Transplant, 25, 256 - 264
Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
Gray MD. et al, (2019), Radiology, 181445 - 181445